http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102283812-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0a5a3e19633705b74da621161347d5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c07f3aa0896bad68f16b8d9ab8a4712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a13cd4b3c39adc88d6a3e52641b8801d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64a338e11def650a51bec0b02acf864 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34acf5b1d9bacc47920d0a8a95f7fc63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf3bda34acf0cc51a01f1a66356fec1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09b859c412e08ad545afe5afae5a854 |
| publicationDate | 2015-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102283812-B |
| titleOfInvention | Nanoparticle preparation for treating brain diseases |
| abstract | The invention discloses a nanoparticle preparation for treating brain diseases. The nanoparticle preparation comprises the following raw materials in part by weight: 10 to 250mg of geniposide or total iridoid glycoside of cape jasmine fruit serving as a medicament carried by the nanoparticle preparation; 50 to 300mg of polylactic acid-glycolic acid copolymer serving as a carrier of the nanoparticle preparation; and 200 to 500mg of polyvinyl alcohol and 1 to 30mg of tween-80 or hydrogenated castor oil serving as emulsifiers of the nanoparticle preparation. The invention also discloses the nanoparticle preparation, which is modified by chitosan, wherein the geniposide or total iridoid glycoside of cape jasmine fruit serves as a carried medicament of the nanoparticle preparation. The nanoparticle preparation is prepared by a multiple emulsion-solvent evaporation method. The preparation is administrated through nasal cavities, so the concentration of the geniposide or total iridoid glycoside of cape jasmine fruit in brain tissues is effectively increased. Compared with preparations prepared from the geniposide or total iridoid glycoside of cape jasmine fruit, which are administrated through gastrointestinal tracts, intramuscular injection and the like, the nanoparticle preparation has the advantages of small dosage and high patient compliance. |
| priorityDate | 2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.